RESPERIDONE LONG ACTING 37.5 MG INJ
Dg Armed Forces Medical Service · Delhi · Pharmaceuticals · open
Key facts
- EMD: ₹1.1L
- Published: 21 Aug 2026
- Closing date: 31 Aug 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Defence
Description
Tender for supply of 800 units of Resperidone Long Acting 37.5 mg Injection by the Armed Forces Medical Service, Ministry of Defence, with a bid validity of 180 days, EMD of 107000 INR, and ePBG of 3% for 24 months.
Eligibility & requirements
- Experience required: 3 years
- Past performance: 10%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Supporting documents for experience and turnover relaxation, OEM Authorization Certificate, OEM Annual Turnover proof
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: value wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (1)
- Resperidone Long Acting 37.5 MG Injection — Qty: 800 unit
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals